EFFECT OF SULFINPYRAZONE ON TOTAL SERUM CHOLESTEROL IN GOUT
- 1 August 1964
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 248 (2) , 164-174
- https://doi.org/10.1097/00000441-196408000-00005
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Results of a clinical trial of g‐28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjectsArthritis & Rheumatism, 1958
- GOUT AND DIABETES1958
- Serum Lipid Levels in Normal PersonsCirculation, 1957
- A POTENT NEW URICOSURIC AGENT, THE SULFOXIDE METABOLITE OF THE PHENYLBUTAZONE ANALOGUE, G-256711957
- GOUT AND DIABETES1957
- Weight Gain from Simple Overeating. II. Serum Lipids and Blood Volume 1Journal of Clinical Investigation, 1957
- The Interrelationships of Serum Lipids in Men and Women Past Sixty-Five Years of Age and Their Bearing on AtherosclerosisCirculation, 1953
- Obesity, Fat Metabolism and Cardiovascular DiseaseCirculation, 1952
- Plasma Cholesterol Levels during Rapid Weight ReductionCirculation, 1951
- LIVER FUNCTION AND SERUM PROTEIN STRUCTURE IN GOUTAnnals of Internal Medicine, 1949